Brain Function in Children With Congenital Heart Disease (CHD)
NCT ID: NCT02814539
Last Updated: 2019-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2016-03-31
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Executive Functions in Adults With Congenital Heart Disease
NCT04041557
The Swiss Neurodevelopmental Outcome Registry for Children With CHD
NCT05996211
Neurodevelopment in Infants With Complex Congenital Heart Defects
NCT03104751
Predictive Value of Neurovascular Coupling in Infants With COngenital Heart Disease
NCT06190210
Assessing Neurodevelopment in Congenital Heart Disease.
NCT02996630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
congenital heart disease
children with severe congenital heart disease who undergo open heart surgery during infancy
No interventions assigned to this group
healthy controls
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Cardiopulmonary bypass surgery during first three months of life,
* No genetic syndrome,
* Gestational age \> 37 weeks of gestation.
Exclusion Criteria
* Heart surgery not within first three months of life,
* Born \<37 weeks of gestation,
* Any genetic syndrome detected.
9 Years
14 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Zurich
OTHER
Bea Latal
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bea Latal
Prof Dr med Bea Latal
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bea Latal, MD MPH
Role: PRINCIPAL_INVESTIGATOR
University Childrens Hospital Zurich
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BF_CHD_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.